AI Verdict
VRTX has stronger fundamentals based on our AI analysis.
BSX vs VRTX Fundamental Comparison
| Metric | BSX | VRTX |
|---|---|---|
| Revenue | $5.2B | $3.0B |
| Net Income | $1.3B | $1.0B |
| Net Margin | 25.8% | 34.5% |
| ROE | 5.2% | 5.3% |
| ROA | 3.0% | 3.9% |
| Current Ratio | 1.90x | 3.02x |
| Debt/Equity | 0.42x | 0.01x |
| EPS | $0.90 | $4.02 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
BSX vs VRTX: Frequently Asked Questions
Is BSX or VRTX the better stock in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), VRTX has stronger fundamentals. BSX is graded A (77% confidence) while VRTX is graded A (81% confidence). This is not investment advice.
How does BSX compare to VRTX fundamentally?
BOSTON SCIENTIFIC CORP has ROE of 5.2% vs VERTEX PHARMACEUTICALS INC / MA's 5.3%. Net margins are 25.8% vs 34.5% respectively.
Which stock pays higher dividends, BSX or VRTX?
BSX has a dividend yield of N/A or no dividend while VRTX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in BSX or VRTX for long term?
For long-term investing, consider that BSX has a A grade with 77% confidence, while VRTX has a A grade with 81% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about BSX vs VRTX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For BSX vs VRTX, the AI consensus favors VRTX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.